Occudo Quantitative Strategies’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-45,324
| Closed | -$398K | – | 1071 |
|
|
2023
Q4 | $398K | Buy |
+45,324
| New | +$398K | 0.05% | 457 |
|
|
2023
Q2 | – | Sell |
-21,918
| Closed | -$706K | – | 1343 |
|
|
2023
Q1 | $706K | Sell |
21,918
-18,834
| -46% | -$607K | 0.06% | 414 |
|
|
2022
Q4 | $752K | Buy |
40,752
+24,278
| +147% | +$448K | 0.09% | 373 |
|
|
2022
Q3 | $445K | Sell |
16,474
-27,295
| -62% | -$737K | 0.03% | 704 |
|
|
2022
Q2 | $605K | Buy |
+43,769
| New | +$605K | 0.05% | 554 |
|